SILVER SPRING, Md. — U.S. medical authorities are revisiting the safety of breast implants used by millions of American women, the latest review in a multi-decade debate about their health effects.
You are here
By Matthew Perrone The Associated Press
WASHINGTON — U.S. health officials on Thursday approved a new generic version of EpiPen, the emergency allergy medication that triggered a public backlash due to its rising price tag.
WASHINGTON — U.S. health officials on Monday placed new restrictions on a permanent contraceptive implant that has been subject to reports of painful complications from thousands of women. But the metal implant, called Essure, will remain on the market.
WASHINGTON — A first-of-its kind genetic treatment for blindness will cost $850,000, less than the $1 million price tag that had been expected, but it’s still among the most expensive genetic therapies in the world.
WASHINGTON — Big Tobacco companies return to TV this weekend, decades after they were banned from the airwaves.
WASHINGTON — U.S. regulators want to remove a health claim about the heart benefits of soy from cartons of soy milk, tofu and other foods, saying the latest scientific evidence no longer shows a clear connection.
WASHINGTON — The federal government Friday banned more than a dozen chemicals long-used in antibacterial soaps, saying manufacturers failed to show they are safe and kill germs.
“We have no scientific evidence that they are any better than plain soap and water,” said Dr. Janet Woodcock, the Food and Drug Administration’ drug centre director, in a statement.
WASHINGTON — Federal health officials want to know whether hand sanitizers used by millions of Americans work as well as manufacturers claim and whether there are any health risks to their growing use.